Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Investments

    Investments

    27 August 2024

    Cambridge Index advances 1.1%

    The Cambridge Index rose 223.91 points or 1.1% to close at 20,749.4, as four out of the top ten index heavyweights posted weekly gains in their share price. ...

    2 September 2024

    Nxera Pharma to receive US$35 Million from Neurocrine Biosciences upon positive phase 2 data for partnered Schizophrenia candidate NBI-1117568

    Tokyo, Japan and Cambridge, UK - Nxera Pharma Co., Ltd. - formerly known as Sosei Group or Sosei Heptares – announces it will receive a US$35 million payment from Neurocrine Biosciences, triggered by the successful completion of the Phase 2 trial with NBI-1117568 (NBI-‘568) in adults wi...

    10 September 2024

    Cambridge Index falls 3.6%

    The Cambridge Index dropped 754.87 points or 3.6% to close at 19,960.2, as nine out of the top ten index heavyweights posted weekly losses in their share price. ...

    17 September 2024

    Cambridge Index rises 1.8%

    The Cambridge Index advanced 365.49 points or 1.8% to close at 20,325.7, as three out of the top ten index heavyweights posted weekly gains in their share price. ...

    24 September 2024

    Cambridge Index falls 1.5%

    The Cambridge Index dropped 312.22 points or 1.5% to close at 20,013.5, as five out of the top ten index heavyweights posted weekly losses in their share price. ...

    26 September 2024

    Why climate change investment pays off

    Cost of inaction on climate change far outweighs the cost of proactive investment, says new analysis issued at New York Climate Week. ...

    11 October 2024

    Ex-Darktrace CEO Poppy Gustafsson appointed UK investment minister

    Co-founder of £4bn British tech firm to lead Office for Investment as a minister in Treasury and Department of Business and Trade. ...

    22 October 2024

    Cambridge Index falls 2.1%

    The Cambridge Index declined 410.9 points or 2.1% to close at 19,508.6, as six out of the top ten index heavyweights posted weekly losses in their share price. ...

    23 October 2024

    Cambridge reveals innovation blueprint to become world’s leading science and tech region

    With the aim to achieve the same level of innovation in the next 10 years as the last 25 years. ...

    29 October 2024

    Cambridge Index rises 2.8%

    The Cambridge Index climbed 552.46 points or 2.8% to close at 20,061.1, as four out of the top ten index heavyweights posted weekly gains in their share price. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 14
    • Page 15
    • Current page 16
    • Page 17
    • Page 18
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS